1110 – 1140
Novel ASM: Dr Rhys Thomas, Newcastle
1140 – 1210
Precision genetic therapies in epilepsy: Prof Norman Delanty, Dublin
1210 – 1240
Laser interstitial thermal therapy (LITT): Mr Martin Tisdall, London
1405 – 1420| Investigating the impact of anti-seizure medication in developing human brain slice cultures: Faye McLeod, Newcastle University
1420 – 1435| High Field 7T MRI in a drug resistant pediatric epilepsy cohort: clinical outcome and cortical thickness evaluation: Jonathan O’Muircheartaigh, KCL
1435 – 1450| Dysfunction in lysine metabolism underlies epilepsy and mTORC1 hyperactivity in tuberous sclerosis complex: Felix Chan, Aston University
1450 – 1505| Mapping epileptiform activity using graphene-based thin film devices in a model of glioblastoma-associated epilepsy: Kate Hills, University of Manchester
1505 – 1520| Synergistic positive feedback: a comprehensive model of seizure initiation: Andrew Trevelyan, Newcastle University
1520 – 1535| Heartbeat-evoked potential predicts semiology of functional seizures and distinguishes functional seizures from epileptic seizures of similar semiology: Rohan Kandasamy, National Hospital for Neurology & Neurosurgery
1535 – 1550| Neural correlate of reduced respiratory chemosensitivity during chronic epilepsy: Amol Bhandare, University of Warwick
1550 – 1605| Initial experience using everolimus targeted therapy in the GATOR1 complex epilepsies – a case series: Patrick Moloney, Beaumont Hospital
Dr Ian Minshall GP, Chester
EL01| Monitoring population level health in epilepsy: A National Data Dashboard for Epilepsy in Wales: Joseph Anderson, Aneurin Bevan University Health Board
EL02| Long-term Seizure Freedom in Frontal Lobe Epilepsy is associated with Anterior Thalamo-Cortical Disconnection: Davide Giampiccolo, UCL Institute of Neurology
EL03| A screening pathway for depression and suicidality in people with epilepsy: Richard Chin, University of Edinburgh
EL04| A novel leucine-rich glioma inactivated 1 (LGI1) protein antibody -associated seizure rodent model: Sukhvir Wright, Aston University
EL05| Structural imaging phenotypes in juvenile absence epilepsy: Luisa Delazer, Ludwig- Maximilians Universität München
EL06| Absence seizures and abnormal sleep in a rat model of GRIN2B encephalopathy: Katerina Hristova, Centre for Discovery Brain Sciences
EL07| Comparing Interoception in people with Epilepsy and people with Functional non-epileptic seizures: Samia Elkommos, King’s College London
EL08| Harnessing neurogliaform interneurons to control cortical hyperexcitability in awake mice: Vincent Magloire, UCL
1015 – 1045
What do we mean by AI? Dr Ali-Alim Marvasti, UCL WEISS, Wellcome EPSRC Institute of Surgical Science
1045 – 1115
Deep learning to analyse EEG data in epilepsy: Dr Catarina da Silva, Lourenco, University of TWENTE, Enschede, the Netherlands
1115 – 1145
The role of AI interpretation of MRI in epilepsy: Dr Sophie Adler, Great Ormond Street Hospital, London
Prof Sandor Beniczky, Denmark
Principles of sonification: Nigel Osborne, Composer and Professor of music
Sonification in practice in epilepsy: Prof Mike Trimble, Emeritus Professor of Behavioural Neurology, UCL
Music therapy in epilepsy: Prof Hrvoje Hecimovic, Zagreb, Croatia
NICE and IGAP – synergistic opportunities to improve epilepsy care: Prof Arjune Sen, Oxford
Is it time to re-evaluate our approach to treating epilepsy?
0900 – 0920
Electro-clinical diagnoses: Dr Ronit Pressler, Great Ormond Street Hospital, London
0920 – 0940
Clinical Management of seizures: Prof Matthew Walker, UCL/UCLH
0940 – 1000
Managing comorbidities – cognition, challenging behaviour, neurodevelopmental disorders: Prof Mike Kerr Cardiff
JME: Prof Phil Smith, Cardiff
IGE with GTS: Dr Khalid Hamandi, Cardiff